MSO w/$6M EBITDA

searcher profile

September 12, 2022

by a searcher from Arizona State University in Louisville, KY, USA

We have a successful MSO rolling into our expansion phase. Our model allows us to cut time to payback by 2 years, without needing full integration. Our rocket fuel is a growing TAM (about 2M new customers a year) projected until 2030. We specifically target businesses with 10%-12% EBITDA margins with the proper patient mix to yield 26% - 34% EBITDA blend post-acquisition (a 16% - 22% EBITDA margin improvement) You are welcome to connect or email me directly at redacted
2
7
398
Replies
7
commentor profile
Reply by a lender
from McGill University in Greenwich, CT, USA
Hi Maceo - I sent you an email. My firm, Libertas, is a leading provider of cashflow-based non-dilutive debt to SMBs and lower-middle market companies. Many of our clients use our capital to expand via acquisition. We are quick to close, fund up to $5M in check size, and have steep prepayment discounts - perfect for quickly closing deals. Happy to discuss in further detail and see if Libertas can help you achieve your growth objectives. redacted
commentor profile
Reply by an investor
in Toronto, ON, Canada
We'll happily take a look www.fundscout.ai - we bave 209k investors in our network (that we can reach in 2-4 days) and will handle the entire capital raise process with zero retainers on a success-fee only basis.

Just fill out the form and our team will contact you the same day!
commentor profile
+5 more replies.
Join the discussion